Travere Therapeutics (TVTX) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | -26.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.48% |
| Dec 31, 2025 | -23.68% |
| Sep 30, 2025 | -23.25% |
| Jun 30, 2025 | -23.23% |
| Mar 31, 2025 | -22.93% |
| Dec 31, 2024 | -21.68% |
| Sep 30, 2024 | -18.81% |
| Jun 30, 2024 | -17.50% |
| Mar 31, 2024 | -15.96% |
| Dec 31, 2023 | -7.40% |
| Sep 30, 2023 | 11.97% |
| Jun 30, 2023 | 43.01% |
| Mar 31, 2023 | 51.65% |
| Dec 31, 2022 | 46.28% |
| Sep 30, 2022 | 48.64% |
| Jun 30, 2022 | 49.53% |
| Mar 31, 2022 | 52.40% |
| Dec 31, 2021 | 52.26% |
| Sep 30, 2021 | 51.32% |
| Jun 30, 2021 | 50.25% |
| Mar 31, 2021 | 56.66% |
| Dec 31, 2020 | 42.86% |
| Sep 30, 2020 | 27.99% |
| Jun 30, 2020 | 4.88% |
| Mar 31, 2020 | 2.53% |
| Dec 31, 2019 | 3.77% |
| Sep 30, 2019 | 96.76% |
| Jun 30, 2019 | 99.28% |
| Mar 31, 2019 | 92.94% |
| Dec 31, 2018 | 94.43% |
| Sep 30, 2018 | 90.85% |
| Jun 30, 2018 | 89.34% |
| Mar 31, 2018 | 70.05% |
| Dec 31, 2017 | 68.85% |
| Sep 30, 2017 | 62.50% |
| Dec 31, 2016 | 172.80% |
| Sep 30, 2016 | 115.00% |
| Mar 31, 2016 | 144.82% |